New award for clobetasol cream and ointment with encube ethicals, INC. The base year ordering period is 11/17/2025 to 11/16/2026 with four
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79725D0056
- Awardee
-
Encube Ethicals, Inc. UEI EXP3PQJMXXF6
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Clobetasol Cream and Ointment (VA-25-00041429) Pre-Solicitation · 36E79725R0040 · Posted May 8, 2025
- Last date to order 97% complete
- IDV ceiling
- $6,333,469.80
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Encube Ethicals, Inc. for Clobetasol Propionate 0.05% Cream and Ointment on November 17, 2025, with a ceiling value of $6,333,469.80.
The contract covers two product groups: Group I (Cream) and Group II (Ointment), each in four package sizes ranging from 15 to 60 grams per tube. Clobetasol products will be distributed to the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center through VA and DoD Pharmaceutical Prime Vendor Programs. The procurement falls under NAICS code 325412 (Pharmaceutical Preparation Manufacturing).
The base performance period runs from November 17, 2025 to November 16, 2026, with four one-year option periods extending through November 16, 2030. Estimated annual usage spans 19,351 to 130,598 tubes for Cream and 25,173 to 123,024 tubes for Ointment, depending on package size.
The contract contains no set-aside designation and was awarded unrestricted to the responsible offeror capable of providing uninterrupted supply. The awardee's products must carry unique National Drug Codes and exclusive labeling as specified in the original solicitation (RFP 36E79725R0040). A modification incorporating Section 5 of Executive Order 14398, Clause 52.222-90 (DEI discrimination protections), was incorporated into the contract as of April 2026.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725D0056?
36E79725D0056 was awarded to Encube Ethicals, Inc. by National Acquisition Center (Headquarters) on November 17, 2025.
How much is contract 36E79725D0056 worth?
36E79725D0056's own ceiling is $6,333,470.
Who can order from contract 36E79725D0056?
36E79725D0056 is a single award indefinite delivery contract.
Was contract 36E79725D0056 competed?
The extent of competition for 36E79725D0056 was full and open competition. The government received 7 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV